Quantcast
Channel: STELLAR Phase 2 trial Archives - Mesothelioma Research News
Browsing latest articles
Browse All 5 View Live

Image may be NSFW.
Clik here to view.

Treatment Trio for Mesothelioma Is Safe, Improves Patients’ Survival Rates,...

Combining Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, with standard chemotherapy treatments Alimta (pemetrexed) and Platinol (cisplatin) or Paraplatin...

View Article



Novocure’s STELLAR Trial Enrolls Last Mesothelioma Patient to Test Tumor...

Novocure has enrolled its last patient in the STELLAR trial (NCT02397928) to assess the safety and effectiveness of Tumor Treating Fields (TTFields) in combination with standard chemotherapy in newly...

View Article

TTFields, Which Alternates Forms of Electricity to Kill Mesothelioma Cells,...

The U.S. Food and Drug Administration has granted Humanitarian Use Device (HUD) status to Novocure‘s Tumor Treating Fields (TTFields) for treating pleural mesothelioma. The designation provides...

View Article
Browsing latest articles
Browse All 5 View Live




Latest Images